1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
U.S. Army Medical Research Acquisition Activity (USAMRAA) Extramural Biomedical and Human Performance Research and Development BAA (HT9425-23-S-SOC1) is sponsored by U.S. Army Medical Research Acquisition Activity (USAMRAA). This multi-year rolling BAA supports extramural biomedical and human performance research and development through USAMRAA. It is open to a wide range of military medical research topics.
Get alerted about grants like this
Save a search for “U.S. Army Medical Research Acquisition Activity (USAMRAA)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
A **. gov** website belongs to an official government organization in the United States.
* How to Apply for Grants * **Applicant Resources** * Adobe Software Compatibility * Submitting UTF-8 Special Characters * Encountering Error Messages * Grantor Standard Language * Submitting UTF-8 Special Characters * **Applicant System-To-System** * Reference Implementation * **Grantor System-To-System** * Reference Implementation * SF-424 Individual Family * SF-424 Mandatory Family * SF-424 Short Organization Family * Post-Award Reporting Forms * Country and State Lists Updates * **Manage Subscriptions** * Program Management Office * Grants.
gov Maintenance Calendar View similar opportunities BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense Dept.
of the Army -- USAMRAA Document Type:Grants Notice Funding Opportunity Number:HT9425-23-S-SOC1 Funding Opportunity Title:BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Procurement Contract Category of Funding Activity:Science and Technology and other Research and Development Expected Number of Awards: Assistance Listings:12.
420 -- Military Medical Research and Development Cost Sharing or Matching Requirement:No Last Updated Date:Aug 11, 2023 Original Closing Date for Applications:Jul 31, 2028 Current Closing Date for Applications:Jul 31, 2028 Archive Date:Aug 30, 2028 Estimated Total Program Funding:$ 10,000,000 Award Ceiling:$50,000,000 Eligible Applicants:Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Additional Information on Eligibility: ## Additional Information Agency Name:Dept.
of the Army -- USAMRAA Description:The FY23 -FY28 Broad Agency Announcement for Extramural Biomedical Research and Development - HT9425-23-S-SOC1. Link to Additional Information:[](https://www. grants.
gov/search-results-detail/349586) Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: If you have difficulty accessing the full announcement electronically, please contact: ## Similar Opportunities (identified by AI) #### Health & Human Services * Frequently Asked Questions ## Your session will expire in 3 minutes. To continue working, click on the "OK" button below.
This is being done to protect your privacy. Unsaved changes will be lost.
According to the current listing, eligibility includes: Any eligible entity including universities, nonprofits, and businesses. Confirm the full requirements in the official notice before applying.
The current listing shows $750K to $50M. Verify award ceilings, matching requirements, and allowable costs in the official notice.
U.S. Army Medical Research Acquisition Activity (USAMRAA) Extramural Biomedical and Human Performance Research and Development BAA (HT9425-23-S-SOC1) is funded by U.S. Army Medical Research Acquisition Activity (USAMRAA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The OCRP Outcomes Consortium Development Award supports a multi-institutional research effort conducted by leading ovarian cancer researchers and consumer advocates that specifically focuses on identifying and understanding predictors of disease outcomes in ovarian cancer patients. This effort will be executed through a two-stage approach using two separate award mechanisms: this FY12 Outcomes Consortium Development Award, which will enable the consortium to lay the groundwork for the research project, including proof of concept, and the FY14 Outcomes Consortium Award, which will support the execution of the full research project. Funding Opportunity Number: W81XWH-12-OCRP-OCDA. Assistance Listing: 12.420. Funding Instrument: CA,G. Category: ST. Award Amount: $1.3M total program funding.
Small Business Innovation Research (SBIR) Program 25.1 Solicitation is sponsored by Department of Homeland Security (DHS) Science and Technology Directorate (S&T). The DHS SBIR Program invites U.S. small businesses to submit research proposals addressing technology needs in fentanyl source profiling, data analysis tools, digital injection attack prevention, and wired interconnection cables or adapters.
Operation Stonegarden (OPSG) is a federal grant program administered by FEMA through the Office of the Governor's Public Safety Office that funds enhanced border security cooperation among Customs and Border Protection (CBP), U.S. Border Patrol, and state, local, tribal, and territorial law enforcement agencies. The program supports joint operations to secure land and water border routes, improve intelligence sharing, and expand 287(g) screening operations within correctional facilities. In 2025, the national priority is Supporting Border Crisis Response and Enforcement, covering training, operational coordination, and risk management. Eligible expenses include operational overtime costs, staffing support for screening activities, and training programs in immigration law, civil rights protections, and 287(g) procedures.
DARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read articleOn June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read articleThe BARK program funds dual-use medical products for warfighters and military working dogs — tourniquets, sensors, drug delivery, and CBRN countermeasures. Proposals close June 3, 2026.
Read article